Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Oncoimmunology|February 21, 2020
Checkpoint molecules coordinately restrain hyperactivated effector T cells in the tumor microenvironmentMin Yang, Wenwen Du, Lixian Yi, et al.European Journal of Pharmacology|November 3, 2024
Cordycepin enhances the Anticancer efficacy of PD-L1 blockade by modulating the tumor microenvironment of colon cancerChen Feng, Rongzhang Chen, Xinran Gao, et al.Cancer Immunology, Immunotherapy : CII|June 4, 2024
Enhanced abscopal anti-tumor response via a triple combination of thermal ablation, IL-21, and PD-1 inhibition therapyShaoxian Wu, Hongwei Jiang, Zhang Fang, et al.International Immunopharmacology|February 21, 2026
Mechanistic insights into cordycepin-enhanced CTLA-4 blockade efficacy via Eubacterium rectale-mediated immunomodulation in colon cancerXinran Gao, Chen Feng, Yingni Deng, et al.Cancer Research Communications|August 7, 2023
Synergism Between IL21 and Anti-PD-1 Combination Therapy is Underpinned by the Coordinated Reprogramming of the Immune Cellular Network in the Tumor MicroenvironmentShaoxian Wu, Hao Huang, Runzi Sun, et al.International Journal of Biological Macromolecules|September 6, 2025
NK cells limit the synergistic anti-tumor effect of PD-1 inhibition and βγ-biased IL-2Hongwei Jiang, Shaoxian Wu, Zhang Fang, et al.Cell Reports|November 2, 2022
Mobilizing phospholipids on tumor plasma membrane implicates phosphatidylserine externalization blockade for cancer immunotherapyWeihong Wang, Shaoxian Wu, Zhanpeng Cen, et al.International Immunopharmacology|November 22, 2023
Single-cell RNA sequencing indicates cordycepin remodels the tumor immune microenvironment to enhance TIGIT blockade's anti-tumor effect in colon cancerRongzhang Chen, Chen Feng, Lujun Chen, et al.Pageof 4